Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01456793 · ClinicalTrials.gov registry record · NA

Evaluation of the Effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) Program

A NA study of Pregnancy, sponsored by Mathematica Policy Research.

Completed
Registry status
NA
Development phase
598
Enrollment target
1
Study location

NCT01456793: Completed NA study of Pregnancy, sponsored by Mathematica Policy Research.

NCT01456793 is a NA study of Pregnancy that has completed, run by Mathematica Policy Research. The registered enrollment target is 598 participants, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01456793, a NA study of Pregnancy, has completed, sponsored by Mathematica Policy Research.

COMPLETED
Registry status
NA
Development phase
598 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) program in increasing contraceptive use and reducing repeat pregnancies among pregnant and parenting adolescents in central Ohio.

Conditions Studied

Interventions

  • BEHAVIORAL Teen Options to Prevent Pregnancy (T.O.P.P.)

Study Locations (1)

Ohio

  • OhioHealth Community Partnerships - Columbus

Trial Details

FieldValue
Enrollment Target 598 participants
Start Date 2011-10
Est. Completion 2016-09
Phase NA
Mathematica Policy Research

29 total trials

What the finished NCT01456793 record still lists

NCT01456793 is an interventional study that assigns participants to a tested intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (31% lower).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Teen Options to Prevent Pregnancy (T.O.P.P.) is the first listed.

NCT01456793 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01456793 about?

NCT01456793 is a clinical study titled "Evaluation of the Effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) Program". The purpose of this study is to evaluate the effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) program in increasing contraceptive use and reducing repeat pregnancies among pregnant and parenting adolescents in central Ohio.

What is the current status of trial NCT01456793?

This trial is currently completed. It is a NA study. The enrollment target is 598 participants. The study started on 2011-10. Estimated completion is 2016-09.

What conditions does trial NCT01456793 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT01456793?

The interventions under investigation include: Teen Options to Prevent Pregnancy (T.O.P.P.) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01456793?

This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01456793 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01456793's enrollment target sits among peer trials

598 40th of 191 higher than 152 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06875973 · 599 participants · Phase 3

    Pelacarsen Roll-over Extension Program

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01456793, the US trial registry maintained by the National Library of Medicine. NCT01456793 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.